Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Life expectancy in Down syndrome.

P A Baird, A D Sadovnick

    The Journal of Pediatrics
    |June 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Life expectancy for individuals with Down syndrome is better than previously thought. Survival rates are significantly improved, especially for those without congenital heart defects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Multiple sclerosis in men: management considerations.

    Journal of neurology·2016
    Same author

    Birth outcomes of pregnancies fathered by men with multiple sclerosis.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2014
    Same author

    Colony stimulation factor 1 receptor (CSF1R) is not a common cause of multiple sclerosis.

    European journal of neurology·2013
    Same author

    Reproductive decision making after the diagnosis of multiple sclerosis (MS).

    Multiple sclerosis (Houndmills, Basingstoke, England)·2012
    Same author

    Mitochondrial DNA haplogroups and mutations in children with acquired central demyelination.

    Neurology·2011
    Same author

    HLA-DRB1 confers increased risk of pediatric-onset MS in children with acquired demyelination.

    Neurology·2011
    Same journal

    Standardized Mean Differences Reveal Substantial Selection Bias in Post-Reduction Management of Intussusception.

    The Journal of pediatrics·2026
    Same journal

    Parenteral Lipid Dose and Bilirubin Neurotoxicity in Extremely Preterm Infants: A Factorial Randomized Trial.

    The Journal of pediatrics·2026
    Same journal

    Refining Oxygen-Carrying Capacity Metrics in Assessing Mortality Risk from Pneumonia in Children.

    The Journal of pediatrics·2026
    Same journal

    Time-to-Transfer and Hospitalization Duration for Severe Congenital Heart Defects: Implications for Perinatal Regionalization.

    The Journal of pediatrics·2026
    Same journal

    Multimodal neuromonitoring in neonatal hypoxic-ischemic encephalopathy and the association with neurodevelopmental outcomes: A Multicenter Study.

    The Journal of pediatrics·2026
    Same journal

    KP.2-Adapted BNT162b2 COVID-19 Vaccine Uptake and Effectiveness in Children.

    The Journal of pediatrics·2026
    See all related articles

    Area of Science:

    • Genetics
    • Public Health
    • Pediatrics

    Background:

    • Down syndrome is a genetic disorder with variable life expectancy.
    • Previous estimates of life expectancy for Down syndrome may be outdated.
    • Congenital heart anomalies are common in Down syndrome and impact survival.

    Purpose of the Study:

    • To determine current life expectancy data for individuals with Down syndrome.
    • To compare survival rates between Down syndrome patients with and without congenital heart anomalies.
    • To provide updated statistics for Down syndrome life expectancy.

    Main Methods:

    • Retrospective cohort study using British Columbia Health Surveillance Registry data.
    • Inclusion of 1341 patients with Down syndrome born between 1952-1981.

    Related Experiment Videos

  • Analysis of survival rates at various age points (1, 5, 10, 20, 30 years).

    • Main Results:

    • Survival to age 30 for Down syndrome patients without congenital heart anomalies is 79.2%.
    • Survival to age 30 for Down syndrome patients with congenital heart anomalies is 49.9%.
    • Survival rates are higher than previously believed but remain lower than a comparison group.

    Conclusions:

    • Life expectancy for individuals with Down syndrome has significantly improved.
    • Congenital heart anomalies remain a critical factor influencing survival in Down syndrome.
    • Further research is needed to understand factors contributing to improved survival and disparities.